Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors
Dale J. Calleja(The University of Melbourne), David Komander(Walter and Eliza Hall Institute of Medical Research), Nathan W. Kuchel(The University of Melbourne), Marcel Doerflinger(The University of Melbourne), Kasiram Katneni(Monash University), Theresa Klemm(The University of Melbourne), Bernadine G.C. Lu(The University of Melbourne), Jeffrey P. Mitchell(University of California, Davis), Elly Crighton(Monash University), Melissa Call(The University of Melbourne), Kate E. Jarman(Walter and Eliza Hall Institute of Medical Research), Amanda E. Au(The University of Melbourne), Marc Pellegrini(The University of Melbourne), Richard W. Birkinshaw(The University of Melbourne), Peter E. Czabotar(The University of Melbourne), Ueli Nachbur(The University of Melbourne), Susan A. Charman(Monash University), Bernhard C. Lechtenberg(Walter and Eliza Hall Institute of Medical Research), Kym N. Lowes(The University of Melbourne), Yu Q. Yap(The University of Melbourne), James P. Cooney(The University of Melbourne), Liana Mackiewicz(Walter and Eliza Hall Institute of Medical Research), Guillaume Lessène(The University of Melbourne), Janet Newman(Freedom to Live), T. Blackmore(The University of Melbourne)
Cited by 48
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
|Science Translational Medicine|2015|541
Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
|The EMBO Journal|2020|499
Structural insights into the catalytic mechanism of a family 18 exo-chitinase
|Proceedings of the National Academy of Sciences|2001|462